TY  - GEN
AU  - Lambertini,Matteo
AU  - Poggio,Francesca
AU  - Bruzzone,Marco
AU  - Conte,Benedetta
AU  - Bighin,Claudia
AU  - de Azambuja,Evandro
AU  - Giuliano,Mario
AU  - De Laurentiis,Michele
AU  - Cognetti,Francesco
AU  - Fabi,Alessandra
AU  - Bisagni,Giancarlo
AU  - Durando,Antonio
AU  - Turletti,Anna
AU  - Urracci,Ylenia
AU  - Garrone,Ornella
AU  - Puglisi,Fabio
AU  - Montemurro,Filippo
AU  - Ceppi,Marcello
AU  - Del Mastro,Lucia
TI  - Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial
SN  - 1097-0215
PY  - 2021///0317
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Clinical Trials, Phase III as Topic
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Epirubicin
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Middle Aged
KW  - Multicenter Studies as Topic
KW  - Paclitaxel
KW  - Randomized Controlled Trials as Topic
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Trastuzumab
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1002/ijc.32789
ER  -